The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation

Journal of Bone and Joint Surgery

Volumn 78, Issue 1, 1996, Pages 62-72

  Faris, P M ^a   Ritter, M A ^a   Abels, R I ^b   Ball, G V ^c   Bernini, P M ^d   Bryant, G L ^e   Caperton, E M ^f   Christoferson, L A ^g   De Andrade, J R ^h   Engh, G ⁱ   Furman, W ^j   Harmon, J V ^k   Hillman, R S ^l   Honig, S ^m   Incavo, S ⁿ   Jove, M ^o   Landon, G C ^p   Nicholls, P ^q   Savory, C G ^r   Sculco, T ^s   Slagis, S V ^t   Woodson, R ^u   more..

^a CENTER FOR HIP AND KNEE SURGERY   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^f Recycling Association of Minnesota   (United States)

^g Dakota Medical Center   (United States)

^h EMORY CLINIC   (United States)

ⁱ Anderson Orthopaedic Clinic   (United States)

^j SARASOTA MEMORIAL HOSPITAL   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l MAINE MEDICAL CENTER   (United States)

^m NYU HOSPITAL FOR JOINT DISEASES   (United States)

ⁿ FLETCHER ALLEN HEALTH CARE   (United States)

^o DeKalb Orthopedic Clinic   (United States)

^p MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^q UNIVERSITY OF KENTUCKY   (United States)

^r Hughston Sports Medicine Foundation   (United States)

^s HOSPITAL FOR SPECIAL SURGERY   (United States)

^t UNIVERSITY OF ARIZONA   (United States)

^u UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MULTICENTER STUDY; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION;

EID: 0345593589     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199601000-00009     Document Type: Article

References (24)

1. Adamson, J. W., and Eschbach, J. W.: The use of recombinant human erythropoietin (r-HuEPO) in man. In Biology of Hematopoiesis, pp. 505-517. New York, Wiley-Liss, 1990.
2. Atabek, U.; Spence, R. K.; Pello, M.; Alexander, J.; and Camishion, R.: Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. Arch. Surg., 127: 349-351, 1992.
3. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet, 341: 1227-1232, 1993.
4. Cases, A.; Escolar, G.; Reverter, J. C.; Ordinas, A.; Lopez-Pedret, J.; Revert, L.; and Castillo, R.: Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Internat., 42: 668-672, 1992.
5. Connor, J. P., and Olsson, C. A.: The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery. J. Urol., 147: 131-132, 1992.
6. Eschbach, J. W.; Haley, N. R.; Egrie, J. C.; and Adamson, J. W.: A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney Internat., 42: 407-416, 1992.
7. Fullerton, D. A.; Campbell, D. N.; and Whitman, G. J.: Use of human recombinant erythropoietin to correct severe preoperative anemia. Ann. Thoracic Surg., 51: 825-826, 1991.
8. Gaudiani, V. A., and Mason, H. D.: Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures. Ann. Thoracic Surg., 51: 823-824, 1991.
9. Goodnough, L. T.: Erythropoietin therapy in autologous blood donors. In Hematopoietic Growth Factors in Transfusion Medicine, pp. 105-112. Edited by J. Spivak, W. Drohan, and D. Dooley. New York, Wiley-Liss, 1990.
10. Goodnough, L. T., and Brittenham, G. M.: Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J. Lab. and Clin. Med., 115: 28-35, 1990.
11. Goodnough, L. T.; Rudnick, S.; Price, T. H.; Ballas, S. K.; Collins, M. L.; Crowley, J. P.; Kosmin, M.; Kruskall, M. S.; Lenes, B. A.; Menitove, J. E.; Silberstein, L. E.; Smith, K. J.; Wallas, C. E.; Abels, R.; and Von Tress, M.: Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. New England J. Med., 321: 1163-1168, 1989.
12. Kyo, S.; Omoto, R.; Hirashima, K.; Eguchi, S.; and Fujita, T.: Effect of human recombinant erythropoietin on reduction of homologous blood transfusion in open-heart surgery. A Japanese multicenter study. Circulation, 86 (Supplement II): II413-II418, 1992.
13. Linde, T.; Wahlberg, J.; Wikstrom, B.; and Danielson, B. G.: Outcome of renal transplantation in patients treated with erythropoietin. Clin. Nephrol., 37: 260-263, 1992.
14. McMahon, L. P., and Dawborn, J. K.: Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am. J. Nephrol., 12: 162-169, 1992.
15. Miale, J. B.: Laboratory Medicine: Hematology. Ed. 6. St. Louis, C. V. Mosby, 1982.
16. Pinevich, A. J., and Petersen, J.: Erythropoietin therapy in patients with chronic renal failure. Western J. Med., 157: 154-157, 1992.
17. Rothstein, P.; Roye, D.; Verdisco, L.; and Stern, L.: Preoperative use of erythropoietin in an adolescent Jehovah's Witness. Anesthesiology, 73: 568-570, 1990.
18. Senghas, R. E.: Statistics in The Journal of Bone and Joint Surgery: suggestions for authors [editorial]. J. Bone and Joint Surg., 74-A: 319-320, March 1992.
19. Storring, P. L., and Gaines Das, R. E.: The international standard for recombinant DNA-derived erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins. J. Endocrinol., 134: 459-484, 1992.
20. Tan, C. C.; Eckardt, K. U.; Firth, J. D.; and Rutcliffe, P. J.: Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am. J. Physiol., 263: F474-F481, 1992.
21. Tasaki, T.; Ohio, K.; Hashimoto, C.; Abe, R.; Saitoh, A.; and Kikuchi, S.: Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production. Lancet, 339: 773-775, 1992.
22. Veys, N.; Vanholder, R.; and Lameire, N.: Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin. Am. J. Nephrol., 12: 68-72, 1992.
23. Watanabe, Y.; Fuse, K.; Konishi, T.; Kobayashi, T.; Takazawa, K.; Konishi, E.; and Shibata, Y.: Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann. Thoracic Surg., 51: 767-772, 1991.
24. Watanabe, Y.; Fuse, K.; Naruse, Y.; Kobayashi, T.; Yamamoto, S.; Konishi, K.; Horii, T.; and Shibata, Y.: Subcutaneous use of erythropoietin in heart surgery. Ann. Thoracic Surg., 54: 479-483, 1992.